ESR1 and invasive ductal breast carcinoma: In terms of clinicopathological features of the tumors, one is estrogen receptor (ER) positive with both ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IBC); the other is ER-positive DCIS.